Trial Site Detail
Drug: |
Sorafenib + Vorinostat |
|||
|---|---|---|---|---|
Trial: |
Phase I Vorinostat + Sorafenib in Patients With Advanced Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Unknown |
|||
University of Colorado1665 N. Ursula St. |
Principal Investigator: |
David Ross Camidge MD |
|---|---|
Contact: |
Stacy Grolnic 720-848-0655 stacy.grolnic@uchsc.edu |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
University of Colorado Website: |
http://www.uch.edu/conditions/cancer/index1.aspx |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.